tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mark Purcell, 26 are a HOLD (44.83%), 11 are a SELL (18.97%), 21 are a BUY (36.21%).
Analyst Mark Purcell, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 45.25% that have a potential upside of 19.09% achieved within 307 days.
Mark Purcell’s has documented 113 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 23-Jan-2024.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 1/23/2024. The price target of $120 was fulfilled within 17 days with a profit of $15.17 (14.47%) receiving and performance score of 8.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
2 months 10 days ago
(20-Nov-2024)
0/6 (0%)
$75.62 (112.66%)
Sell
2 months 24 days ago
(06-Nov-2024)
1/11 (9.09%)
$82.61 (131.40%)
2587
Buy
$95
$25.94 (37.56%)
$66
5 months 18 days ago
(12-Aug-2024)
6/7 (85.71%)
$12.48 (15.12%)
360
Buy
$85
$15.94 (23.08%)
$80
8 months ago
(30-May-2024)
4/4 (100%)
$8.23 (10.72%)
390
Buy
$82
$12.94 (18.74%)
$80
9 months 4 days ago
(26-Apr-2024)
4/4 (100%)
$6.83 (9.09%)
296
What Year was the first public recommendation made by Mark Purcell?
